LysoPC(18:1)
|
Basic information |
| Metabolite name | LysoPC(18:1) |
 | N/A |
 |
C04230 |
 |
N/A |
| Synonyms | LPC(18:1) |
| No. of studies | 18 |
|
Basic information |
| Metabolite name | LysoPC(18:1) |
| N/A |
|
C04230 |
|
N/A |
| Synonyms | LPC(18:1) |
| No. of studies | 18 |
|
Relationship between LysoPC(18:1) and depression (count: 18) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M039 | Type1 | CRS group vs. control group | Plasma | Wistar rat | Up |
| Study M061 | Type1 | depressed group vs. control group | Plasma | Human | Up |
| Study M095 | Type1 | CUMS group vs. control group | Serum | Sprague-Dawley rat | Up |
| Study M1024 | Type1 | CUMS group vs. control group | Serum | ICR mouse | Down |
| Study M1024 | Type2 | CUMS + hydroxytyrosol group vs. CUMS group | Serum | ICR mouse | Up |
| Study M1069 | Type1 | depression group vs. control group | Plasma | Human | Up |
| Study M1086 | Type1 | CUMS group vs. control group | Liver | C57BL/6 mouse | Up |
| Study M1105 | Type1 | psychological stress group vs. control group | Faece | C57BL/6 J mouse | Down |
| Study M1117 | Type1 | MDD group vs. control group, Chinese cohort | Plasma | Human | Up |
| Study M122 | Type3 | paroxetine group vs. control group | Hippocampus | BALB/c mouse | Down |
| Study M122 | Type3 | maprotiline group vs. control group | Prefrontal cortex | BALB/c mouse | Up |
| Study M123 | Type3 | rTMS group vs. control group | Prefrontal cortex | Wistar rat | Up |
| Study M124 | Type3 | maprotiline group vs. control group | Prefrontal cortex | BALB/c mouse | Up |
| Study M125 | Type1 | depressed group vs. control group | Plasma | Human | Up |
| Study M582 | Type1 | CUMS group vs. control group | Faece | C57BL/6N mouse | Up |
| Study M582 | Type2 | CUMS + fluoxetine group vs. CUMS group | Faece | C57BL/6N mouse | Down |
| Study M582 | Type2 | CUMS + fluoxetine group vs. CUMS group | Serum | C57BL/6N mouse | Down |
| Study M582 | Type3 | control + fluoxetine group vs. control group | Faece | C57BL/6N mouse | Down |
| Study M582 | Type3 | control + fluoxetine group vs. control group | Serum | C57BL/6N mouse | Down |
| Study M613 | Type1 | CSDS susceptible group vs. control group | Serum | C57BL/6 J mouse | Up |
| Study M789 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |
| Study M789 | Type2 | CUMS + fluoxetine group vs. CUMS group | Plasma | Sprague-Dawley rat | Down |
| Study M880 | Type1 | depression group vs. control group | Prefrontal cortex | Cynomolgus monkey | Up |
| Study M890 | Type1 | CUMS group vs. control group | Plasma | Sprague-Dawley rat | Up |
| Study M955 | Type1 | CUMS group vs. control group | Hippocampus | C57BL/6J mouse | Down |
| Study M955 | Type2 | CUMS + deoiled sunflower seeds group vs. CUMS group | Hippocampus | C57BL/6J mouse | Up |
| Study M955 | Type2 | CUMS + deoiled and dechlorogenic acid-enriched sunflower seeds group vs. CUMS group | Hippocampus | C57BL/6J mouse | Up |